Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis
Simon Hohenester(GlaxoSmithKline (Germany)), Christian Rust(Krankenhaus Barmherzige Brüder)
American Journal of Physiology-Gastrointestinal and Liver Physiology
June 7, 2018
Cited by 55
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k